Prognostic significance of dobutamine stress echocardiography in patients with chronic kidney disease and known or suspected coronary artery disease: a 5-year follow-up study
- PMID: 39311944
- DOI: 10.1007/s00380-024-02464-9
Prognostic significance of dobutamine stress echocardiography in patients with chronic kidney disease and known or suspected coronary artery disease: a 5-year follow-up study
Abstract
Dobutamine stress echocardiography (DSE) is an effective noninvasive modality for evaluating coronary artery disease (CAD), with high accuracy. However, data on the prognostic value of DSE in patients with chronic kidney disease (CKD) are limited. This study aims to assess the prognostic significance of DSE in patients with CKD and known or suspected CAD. We included consecutive patients with CKD stage 3 or higher and known or suspected CAD who underwent clinically indicated DSE between 2007 and 2017. The primary endpoint was all-cause mortality at 5 years. Univariable and multivariable analyses were conducted to identify predictors of all-cause mortality, with a p value < 0.05 considered statistically significant. A total of 274 patients were included in the study. The mean age was 64.0 ± 13.1 years, with 54% being male and 13.1% having known CAD. Among the patients, 64.6% had advanced CKD (≥ stage 4). Abnormal DSE was observed in 62 patients (22.6%). During a follow-up period of 7.0 ± 3.5 years, 78 patients (28.5%) died. The mortality rate was significantly higher in patients with abnormal DSE compared to those with normal DSE (48.4% vs. 22.6%, p < 0.001). Multivariable analysis identified age (hazard ratio [HR] 1.03, 95% confidence interval [CI] 1.008-1.05, p = 0.005), New York Heart Association (NYHA) functional class (HR 1.60, 95% CI 1.05-2.43, p = 0.03), and chronotropic index < 0.73 (HR 2.61, 95% CI 1.60-4.25, p < 0.001) as independent predictors of mortality. Conversely, a normal DSE result was found to be a protective factor (HR 0.49, 95% CI 0.30-0.81, p = 0.005). In conclusion, DSE demonstrated significant prognostic value in patients with CKD and known or suspected CAD. Age, NYHA functional class, and a chronotropic index < 0.73 were identified as independent predictors of all-cause mortality.
Keywords: Chronic kidney disease; Coronary artery disease; Dobutamine stress echocardiography; Prognosis.
© 2024. Springer Nature Japan KK, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Ethical approval and consent to participate: This study was approved by the Siriraj Institutional Review Board (SIRB), Faculty of Medicine, Siriraj Hospital, Mahidol University (COA no. Si 104/2023). All methods involving human data were conducted in accordance with the Declaration of Helsinki. The requirement for consent was waived by the SIRB due to the study’s retrospective nature and the removal of all personal identifying information. Consent for publication: Not applicable.
Similar articles
-
Prognostic value of dobutamine stress echocardiography for the long-term outcomes in kidney transplant candidates.Cardiovasc Diagn Ther. 2024 Oct 31;14(5):899-910. doi: 10.21037/cdt-24-174. Epub 2024 Sep 23. Cardiovasc Diagn Ther. 2024. PMID: 39513139 Free PMC article.
-
Dobutamine stress cardiac magnetic resonance versus echocardiography for the assessment of outcome in patients with suspected or known coronary artery disease. Are the two imaging modalities comparable?Int J Cardiol. 2014 Feb 1;171(2):153-60. doi: 10.1016/j.ijcard.2013.11.038. Epub 2013 Nov 23. Int J Cardiol. 2014. PMID: 24342416
-
Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates.Eur J Echocardiogr. 2005 Oct;6(5):327-35. doi: 10.1016/j.euje.2005.04.011. Eur J Echocardiogr. 2005. PMID: 15985387
-
Diagnostic accuracy of dobutamine stress echocardiography in the detection of cardiac allograft vasculopathy in heart transplant recipients: A systematic review and meta-analysis study.Echocardiography. 2019 Mar;36(3):528-536. doi: 10.1111/echo.14268. Epub 2019 Feb 6. Echocardiography. 2019. PMID: 30726558
-
Long-term prognostic value of contemporary stress echocardiography in patients with suspected or known coronary artery disease: systematic review and meta-analysis.Heart. 2024 Nov 19;110(23):1349-1356. doi: 10.1136/heartjnl-2024-324534. Heart. 2024. PMID: 39179369 Free PMC article.
References
-
- Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2012) United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 59(1 Suppl 1):A7, e1-420 - PubMed
-
- Wang LW, Fahim MA, Hayen A, Mitchell RL, Baines L, Lord S, Craig JC, Webster AC (2011) Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008691.pub2 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous